213 related articles for article (PubMed ID: 35541921)
1. Toosendanin, a novel potent vacuolar-type H
Dong Y; Zhu G; Wang SF; Keon KA; Rubinstein JL; Zeng SX; Zhang S; Chen QL; Fu J; Li M; Shen HM; Lu JJ; Chen XP; Lu JH
Int J Biol Sci; 2022; 18(7):2684-2702. PubMed ID: 35541921
[TBL] [Abstract][Full Text] [Related]
2. The macrophage-specific V-ATPase subunit ATP6V0D2 restricts inflammasome activation and bacterial infection by facilitating autophagosome-lysosome fusion.
Xia Y; Liu N; Xie X; Bi G; Ba H; Li L; Zhang J; Deng X; Yao Y; Tang Z; Yin B; Wang J; Jiang K; Li Z; Choi Y; Gong F; Cheng X; O'Shea JJ; Chae JJ; Laurence A; Yang XP
Autophagy; 2019 Jun; 15(6):960-975. PubMed ID: 30681394
[TBL] [Abstract][Full Text] [Related]
3. Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy.
Zhang S; Dong Y; Chen X; Tan CSH; Li M; Miao K; Lu JH
Chin Med; 2022 May; 17(1):55. PubMed ID: 35524271
[TBL] [Abstract][Full Text] [Related]
4. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion.
Mauvezin C; Neufeld TP
Autophagy; 2015; 11(8):1437-8. PubMed ID: 26156798
[TBL] [Abstract][Full Text] [Related]
5. Follicular lymphoma-associated mutations in the V-ATPase chaperone VMA21 activate autophagy creating a targetable dependency.
Wang F; Yang Y; Boudagh G; Eskelinen EL; Klionsky DJ; Malek SN
Autophagy; 2022 Aug; 18(8):1982-2000. PubMed ID: 35287545
[TBL] [Abstract][Full Text] [Related]
6. The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases.
Song Q; Meng B; Xu H; Mao Z
Transl Neurodegener; 2020 May; 9(1):17. PubMed ID: 32393395
[TBL] [Abstract][Full Text] [Related]
7. Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A.
Lu Y; Dong S; Hao B; Li C; Zhu K; Guo W; Wang Q; Cheung KH; Wong CW; Wu WT; Markus H; Yue J
Autophagy; 2014; 10(11):1895-905. PubMed ID: 25483964
[TBL] [Abstract][Full Text] [Related]
8. Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy.
Shi Y; Tan SH; Ng S; Zhou J; Yang ND; Koo GB; McMahon KA; Parton RG; Hill MM; Del Pozo MA; Kim YS; Shen HM
Autophagy; 2015; 11(5):769-84. PubMed ID: 25945613
[TBL] [Abstract][Full Text] [Related]
9. Autophagosome-lysosome fusion is independent of V-ATPase-mediated acidification.
Mauvezin C; Nagy P; Juhász G; Neufeld TP
Nat Commun; 2015 May; 6():7007. PubMed ID: 25959678
[TBL] [Abstract][Full Text] [Related]
10. Ups and downs of lysosomal pH: conflicting roles of LAMP proteins?
Handy J; Macintosh GC; Jenny A
Autophagy; 2024 Feb; 20(2):437-440. PubMed ID: 37960894
[TBL] [Abstract][Full Text] [Related]
11. The marine natural product manzamine A targets vacuolar ATPases and inhibits autophagy in pancreatic cancer cells.
Kallifatidis G; Hoepfner D; Jaeg T; Guzmán EA; Wright AE
Mar Drugs; 2013 Sep; 11(9):3500-16. PubMed ID: 24048269
[TBL] [Abstract][Full Text] [Related]
12. Roles for H
Lee H; Koh JY
Glia; 2021 May; 69(5):1110-1125. PubMed ID: 33314298
[TBL] [Abstract][Full Text] [Related]
13. Autolysosome biogenesis and developmental senescence are regulated by both Spns1 and v-ATPase.
Sasaki T; Lian S; Khan A; Llop JR; Samuelson AV; Chen W; Klionsky DJ; Kishi S
Autophagy; 2017 Feb; 13(2):386-403. PubMed ID: 27875093
[TBL] [Abstract][Full Text] [Related]
14. The role of endolysosomal trafficking in anticancer drug resistance.
Hussein NA; Malla S; Pasternak MA; Terrero D; Brown NG; Ashby CR; Assaraf YG; Chen ZS; Tiwari AK
Drug Resist Updat; 2021 Jul; 57():100769. PubMed ID: 34217999
[TBL] [Abstract][Full Text] [Related]
15. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
Niikura K; Takano M; Sawada M
Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
[TBL] [Abstract][Full Text] [Related]
16. A novel potent autophagy inhibitor ECDD-S27 targets vacuolar ATPase and inhibits cancer cell survival.
Paha J; Kanjanasirirat P; Munyoo B; Tuchinda P; Suvannang N; Nantasenamat C; Boonyarattanakalin K; Kittakoop P; Srikor S; Kongklad G; Rangkasenee N; Hongeng S; Utaisincharoen P; Borwornpinyo S; Ponpuak M
Sci Rep; 2019 Jun; 9(1):9177. PubMed ID: 31235856
[TBL] [Abstract][Full Text] [Related]
17. Cancer with low cathepsin D levels is susceptible to vacuolar (H
Kitazawa S; Nishizawa S; Nakagawa H; Funata M; Nishimura K; Soga T; Hara T
Cancer Sci; 2017 Jun; 108(6):1185-1193. PubMed ID: 28317223
[TBL] [Abstract][Full Text] [Related]
18. The integral membrane protein ITM2A, a transcriptional target of PKA-CREB, regulates autophagic flux via interaction with the vacuolar ATPase.
Namkoong S; Lee KI; Lee JI; Park R; Lee EJ; Jang IS; Park J
Autophagy; 2015; 11(5):756-68. PubMed ID: 25951193
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1 signaling.
Valapala M; Wilson C; Hose S; Bhutto IA; Grebe R; Dong A; Greenbaum S; Gu L; Sengupta S; Cano M; Hackett S; Xu G; Lutty GA; Dong L; Sergeev Y; Handa JT; Campochiaro P; Wawrousek E; Zigler JS; Sinha D
Autophagy; 2014 Mar; 10(3):480-96. PubMed ID: 24468901
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of lysosomes activates the MTORC1 signaling pathway in chondrocytes in an autophagy-independent manner.
Newton PT; Vuppalapati KK; Bouderlique T; Chagin AS
Autophagy; 2015; 11(9):1594-607. PubMed ID: 26259639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
